Bitcoin miner Cango sold 4,451 BTC for roughly $305 million to repay part of a Bitcoin-backed loan and accelerate its expansion into AI compute infrastructure. Bitcoin miner Cango sold 4,451 BTC for roughly $305 million to repay part of a Bitcoin-backed loan and accelerate its expansion into AI compute infrastructure.

Bitcoin Miner Cango Sells $305M in BTC to Fund AI Compute Push

2026/02/10 12:56
2 min read
  • Cango sold 4,451 BTC for $305 million to repay debt, leaving it with 7,474 BTC in reserve as the stock continues to trade below $1.00.
  • The company appointed former Zoom executive Jack Jin as CTO to lead its pivot into AI “inference” computing using its existing mining infrastructure.
  • Despite the shift, Cango remains active in mining, producing 500 BTC in January while planning to sell future rewards to fund its new AI business line.

Bitcoin miner Cango said it sold 4,451 Bitcoin (BTC) over the weekend for roughly US$305 million (AU$466 million), using the full amount to repay part of a Bitcoin-backed loan. 

Cango said it plans to use its grid-connected mining infrastructure to provide distributed computing capacity for AI, while still running a Bitcoin mining operation. It added that it will manage capital between the two businesses under a “disciplined” allocation approach.

The company also named Jack Jin, previously with Zoom, as CTO to help build the AI line. Cango stock was trading below $0.95 and is down about 62% over the past six months. Cango shares fell about 3% after the announcement.

Cango remains committed to its mining operations, with a continued focus on enhancing mining economics and seeking an optimal balance between hashrate scale and operational efficiency. The company will be guided by a disciplined framework for asset allocation in pursuit of long-term value creation.

Cango

Related: Bitcoin Slump Hits Saylor’s Strategy at the Worst Possible Moment

CEO Says Selling to Continue

Cango said it operates more than 40 sites across four regions, mining nearly 500 BTC in January and selling 550 BTC during the month for about US$39 million (AU$59 million). 

It ended January holding 7,474.6 BTC, valued at about US$528 million (AU$807.8 million). CEO Paul Yu said the company expects to keep selling part of newly mined BTC to fund expansion of its AI “inference” platform and near-term growth needs.

Bitcoin was last near US$70,727 (AU$108,212), down about 0.2% over 24 hours, roughly 10% lower on the week, and about 44% below its October peak of US$126,080 (AU$192,902).

Related: House Democrats Probe Trump-Linked Crypto Firm Over $500M UAE Investment

The post Bitcoin Miner Cango Sells $305M in BTC to Fund AI Compute Push appeared first on Crypto News Australia.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$69,010.03
$69,010.03$69,010.03
-0.83%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26